Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, Liu Q, Dou R, Xiong B. · 2019
Read Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. by Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, Liu Q, Dou R, Xiong B. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6441214.txt.
Introduction
Wei and co-authors map a feedback loop between colorectal cancer cells and tumor-associated macrophages that powers metastasis through circulating tumor cells. Tumor tissue with dense CD163-positive macrophages at the invasive front showed more mesenchymal change, more mesenchymal circulating cells, and worse patient outcomes.
Macrophages bathed in tumor signals released IL6, which fired the JAK2/STAT3 pathway in cancer cells and shut down miR-506-3p, a brake on the gene FoxQ1. Freed FoxQ1 raised production of CCL2, a call that recruits still more macrophages. Blocking CCL2 or IL6 broke the loop in animals and cut metastasis, exposing two drug points in one circuit.
Catalog record
| CREATOR | Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, Liu Q, Dou R, Xiong B. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 84 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis By Chen Wei, Chaogang Yang, Shuyi Wang, Dongdong Shi, Chunxiao Zhang, Xiaobin Lin, Qing Liu, Rongzhang Dou, Bin Xiong Published in: Molecular Cancer DOI: 10.1186/s12943-019-0976-4 ABSTRACT Background Tumor-associated macrophages (TAMs) are major components of tumor microenvironment that frequently associated with tumor metastasis in human cancers. Circulating tumor cell (CTC), originating from primary tumor sites, is considered to be the precursors of tumor metastasis. However, the regulatory mechanism of TAMs in CTC-mediated tumor metastasis still remains unclear. Methods Immunohistochemical staining was used to detect the macrophages infiltration (CD68 and CD163), epithelial–mesenchymal transition (EMT) markers (E-cadherin and Vimentin) expression in serial sections of human colorectal cancer (CRC) specimens. Then, the correlations between macrophages infiltration and clinicopathologic features, mesenchymal CTC ratio, and patients’ prognosis were analyzed. A co-culture assay in vitro was used to evaluate the role of TAMs on CRC EMT, migration and invasion, and ELISA, luciferase reporter assay and CHIP were performed to uncover the underlying mechanism. Furthermore, an in vivo model was carried out to confirm the effect of TAMs on mesenchymal CTC-mediated metastasis. Results Clinically, CD163+ TAMs infiltrated in invasive front was associated with EMT, mesenchymal CTC ratio, and poor prognosis in patients with CRC. CRC–conditioned macrophages regulated EMT program to enhance CRC cells migration and invasion by secreting IL6. TAMs-derived IL6 activated the JAK2/STAT3 pathway, and activated STAT3 transcriptionally inhibited the tumor suppressor miR-506-3p in CRC cells. miR-506-3p, a key miRNA regulating FoxQ1, was downregulated in CRC cells, resulting in increased FoxQ1 expression, which in turn led to the production of CCL2 that promoted macrophage recruitment. Inhibition of CCL2 or IL6 broke this loop and reduced macrophage migration and mesenchymal CTC-mediated metastasis, respectively. Conclusions Our data indicates that TAMs induce EMT program to enhance CRC migration, invasion, and CTC-mediated metastasis by regulating the JAK2/STAT3/miR-506-3p/FoxQ1 axis, which in turn leads to the production of CCL2 that promote macrophage recruitment, revealing a new cross-talk between immune cells and tumor cells in CRC microenvironment. Electronic supplementary material The online version of this article (10.1186/s12943-019-0976-4) contains supplementary material, which is available to authorized users. BACKGROUND Colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related mortality worldwide [1]. Metastasis, a multi-step complex process involving multiple factors, is still the main cause for CRC-related deaths [2]. Circulating tumor cell (CTC), originating from primary tumor or metastatic sites, is considered to be the precursors of metastases [3]. Previously, our group reported several methods for CTC capture and identification, and demonstrated CTCs detection was closely associated with multiple clinicopathological factors that predicted high metastatic risk in different solid cancers, including gastric, colorectal and hepatocellular cancer [4–7]. Subsequently, we found that only quantifying the CTC count is not sufficient to explain the important role of CTC in the metastasis process, nor can it understand the mechanisms of CTC-mediated metastasis. Meanwhile, we also found that CTC could undergo epithelial-mesenchymal transition (EMT). Moreover, numerous studies demonstrated mesenchymal CTC (MCTC) had more prognostic value than total CTC, which was positively associated with tumor progression and poor patient’s survival in CRC, and knowing about the phenotype traits of CTC could give more information about CRC development [8, 9]. Currently, EMT in cancer, as known to increase cell motility and invasive potential, has been proposed to play the critical role in CTC generation [10]. CTC, which gains more mesenchymal traits by EMT, is easy to survive and metastasize [11, 12]. Therefore, exploring the underlying mechanisms of CTC EMT have great significance for further understanding the metastatic process in CRC. Tumor microenvironment (TME) represents the necessary prerequisite for cancer progression and metastasis [13]. Macrophages in the TME, referred to as tumor-associated macrophages (TAMs), are one of the most abundant types of cells, and exhibit different phenotypes and functions in response to various microenvironmental signals generated from tumor and stromal cells [14]. At present, numerous studies have showed that the localization and density of TAMs are associated with poor clinical outcome in several kinds of solid cancers, including bladder, breast, renal, prostate and gastric cancer [15–19]. In terms of CRC, the exact roles of TAMs are seem to be somewhat contradictory [20, 21]. Noteworthy, emerging studies have suggested that TAMs play important roles in tumor metastases by regulating EMT of cancer cells. In hepatocellular carcinoma (HCC), HCC-derived IL-8 stimulated the M2 polarization of TAMs, which promoted the EMT and invasive potential of HCC cells [22]. Additionally, Wang and colleagues revealed that pancreatic cancer (PC) cells activated macrophages to the M2 phenotype, which then promoted EMT progress to increase migration and invasion of PC cells [23]. Reciprocally, Su et al. showed that cancer cells that have undergone EMT secreted GM-CSF to promote macrophages recruitment, thereby mediating breast cancer metastasis [24]. However, the roles and mechanisms of the crosstalk between TAMs and cancer cells in EMT of CRC are still unclear. Given the crucial roles of TAMs, EMT and CTC in dictating CRC metastasis, we speculated that the crosstalk between TAMs and tumor cells could promote MCTC-mediated tumor metastasis by regulating the EMT program. In the present study, our results showed that CD163+ TAMs at invasive front were significantly correlated with EMT status, MCTC ratio, and patients’ prognosis in CRC. In vitro and in vivo experimental evidences also showed a significant increase in tumor EMT to enhance migration, invasion and metastasis in the presence of TAMs, confirming their pro-tumor functions in CRC. Further mechanistic studies revealed that TAMs induce EMT in CRC cells by regulating the STAT3/miR-506-3p/FoxQ1 axis, which in turn lead to the production of CCL2 to favor macrophages recruitment. These findings demonstrate a positive feedback loop between cancer cells and TAMs promotes CRC metastasis by regulating the EMT program of CTC, contributing to new insight concerning TME and CRC progression. METHODS Patients and tissue samples Primary CRC tissue samples were obtained from 81 patients who underwent curative resection at Zhongnan Hospital of Wuhan University (Wuhan, China). All included patients were identified as adenocarcinoma of colorectal by histopathology and had available preoperative CTC and survival data. Moreover, all patients were devoid of neoadjuvant chemotherapy or radiotherapy before surgical resection and did not be diagnosed with autoimmune diseases. Peripheral blood (PB) samples with a volume of 2.5 ml from all patients were collected in EDTA-containing tubes (BD, USA) at the time of one day before surgery. Formalin-fixed, paraffin-embedded (FFPE) cancer tissue specimens were obtained from these patients after surgery. All samples were collected with informed consent from patients, and all related procedures were performed with the approval of the internal review and ethics boards of Zhongnan Hospital of Wuhan University. Immunohistochemistry Paraffin-embedded samples were serially sectioned at 4 μm thickness. Antigen retrieval was performed by a pressure cooker for 30 min in 0.01 M citrate buffer (pH 6.0), followed by treatment with 3% hydrogen peroxide for 5 min. Specimens were incubated with monoclonal antibodies against human CD68 (1:500; Abcam, USA), CD163 (1:50; Abcam, USA), E-cadherin (1:200; CST, USA), Vimentin (1:200; CST, USA), IL6 (1:100; CST, USA) and FoxQ1 (1:100; Sigma-Aldrich, USA) overnight at 4 degree. Immunostaining was performed using DAB or Permanent Red (Dako) according to the manufacturer’s instructions. For negative